Treatment and survival of patients with small cell lung cancer and brain metastasis

ConclusionAlthough WBRT combined with systemic therapy offer better intracranial control in patients with SCLC and BM, this approach is not superior to the other approaches in terms of OS benefits. Emerging systemic therapies, such as immunotherapy, may be used as alternative or adjunctive treatments for specific patient populations. Further studies are warranted to refine treatment selection.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research